These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34930782)

  • 1. Defective Allelic Exclusion by IgD in the Absence of Autoantigen.
    Renna V; Surova E; Khadour A; Datta M; Amendt T; Hobeika E; Jumaa H
    J Immunol; 2022 Jan; 208(2):293-302. PubMed ID: 34930782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous antigen tunes the responsiveness of naive B cells but not T cells.
    Zikherman J; Parameswaran R; Weiss A
    Nature; 2012 Sep; 489(7414):160-4. PubMed ID: 22902503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
    Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
    J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgD attenuates the IgM-induced anergy response in transitional and mature B cells.
    Sabouri Z; Perotti S; Spierings E; Humburg P; Yabas M; Bergmann H; Horikawa K; Roots C; Lambe S; Young C; Andrews TD; Field M; Enders A; Reed JH; Goodnow CC
    Nat Commun; 2016 Nov; 7():13381. PubMed ID: 27830696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.
    Quách TD; Manjarrez-Orduño N; Adlowitz DG; Silver L; Yang H; Wei C; Milner EC; Sanz I
    J Immunol; 2011 Apr; 186(8):4640-8. PubMed ID: 21398610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of autoreactive B cells by IgM and IgD B cell receptors: maintaining a fine balance.
    Noviski M; Zikherman J
    Curr Opin Immunol; 2018 Dec; 55():67-74. PubMed ID: 30292928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactivity and the positive selection of B cells.
    Übelhart R; Jumaa H
    Eur J Immunol; 2015 Nov; 45(11):2971-7. PubMed ID: 26350303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells.
    Soulas P; Koenig-Marrony S; Julien S; Knapp AM; Garaud JC; Pasquali JL; Martin T
    Eur J Immunol; 2002 Sep; 32(9):2623-34. PubMed ID: 12207347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors.
    Duty JA; Szodoray P; Zheng NY; Koelsch KA; Zhang Q; Swiatkowski M; Mathias M; Garman L; Helms C; Nakken B; Smith K; Farris AD; Wilson PC
    J Exp Med; 2009 Jan; 206(1):139-51. PubMed ID: 19103878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Immune Responses and Affinity Maturation Are Controlled by IgD.
    Amendt T; Ayoubi OE; Linder AT; Allies G; Young M; Setz CS; Jumaa H
    Front Immunol; 2021; 12():709240. PubMed ID: 34434193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation.
    Maity PC; Blount A; Jumaa H; Ronneberger O; Lillemeier BF; Reth M
    Sci Signal; 2015 Sep; 8(394):ra93. PubMed ID: 26373673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.
    Inaoki M; Sato S; Weintraub BC; Goodnow CC; Tedder TF
    J Exp Med; 1997 Dec; 186(11):1923-31. PubMed ID: 9382890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory.
    Koenig-Marrony S; Soulas P; Julien S; Knapp AM; Garaud JC; Martin T; Pasquali JL
    J Immunol; 2001 Feb; 166(3):1463-70. PubMed ID: 11160185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate.
    Noviski M; Mueller JL; Satterthwaite A; Garrett-Sinha LA; Brombacher F; Zikherman J
    Elife; 2018 Mar; 7():. PubMed ID: 29521626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors.
    Feuerstein N; Shivers D; Chen F; Eisenberg RA; Finkel TH
    Int Immunol; 2003 Aug; 15(8):975-85. PubMed ID: 12882835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.